A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

NCT02741245 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

321

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Ezetimibe 10 mg
DRUG: Rosuvastatin 2.5 mg
DRUG: Placebo for Ezetimibe
DRUG: Placebo for Rosuvastatin

Sponsor

Organon and Co